Category: Vasoactive Intestinal Peptide Receptors

´╗┐Also, this view fails to realize the potential double-edged role of insulin in treating hyperglycemia while driving the non-glycemic diseases of T2D

´╗┐Also, this view fails to realize the potential double-edged role of insulin in treating hyperglycemia while driving the non-glycemic diseases of T2D. is usually proposed to act as double-edged agent, namely, to interfere with glycemic control by disrupting the insulin receptor-Akt transduction pathway, while concomitantly driving the non-glycemic diseases of T2D. The mTORC1-centric paradigm may […]